Veterinary Medicines

AVINEW NEO EFFERVESCENT TABLET FOR CHICKENS AND TURKEYS

Not authorised
  • Newcastle disease virus, strain VG/GA, Live
Download as PDF

Product identification

Medicine name:
AVINEW NEO EFFERVESCENT TABLET FOR CHICKENS AND TURKEYS
Avinew NEO bruistablet voor kippen en kalkoenen
Active substance:
  • Newcastle disease virus, strain VG/GA, Live
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
  • Chicken (broiler)
  • Turkey
Route of administration:
  • Ocular use
  • Oral use
  • Oculonasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain VG/GA, Live
    5.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Ocular use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Oral use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Oculonasal use
    • Turkey
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:
  • Box of 10 blisters of 10 tablets of 2,000 doses
  • Box of 1 blister of 10 tablets of 1,000 doses
  • Box of 1 blister of 10 tablets of 2,000 doses
  • Box of 10 blisters of 10 tablets of 1,000 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Netherlands B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 117276
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0296/001

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/08/2022
Download